- Home
- BSX vs DHR Comparison
BSX vs DHR Comparison
Compare BSX & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- DHR
- Stock Information
- Founded
- BSX 1979
- DHR 1969
- Country
- BSX United States
- DHR United States
- Employees
- BSX N/A
- DHR N/A
- Industry
- BSX Medical/Dental Instruments
- DHR Industrial Machinery/Components
- Sector
- BSX Health Care
- DHR Industrials
- Exchange
- BSX Nasdaq
- DHR Nasdaq
- Market Cap
- BSX 146.2B
- DHR 148.8B
- IPO Year
- BSX 1992
- DHR N/A
- Fundamental
- Price
- BSX $99.78
- DHR $209.32
- Analyst Decision
- BSX Strong Buy
- DHR Strong Buy
- Analyst Count
- BSX 19
- DHR 17
- Target Price
- BSX $124.53
- DHR $247.75
- AVG Volume (30 Days)
- BSX 8.0M
- DHR 3.8M
- Earning Date
- BSX 10-22-2025
- DHR 10-21-2025
- Dividend Yield
- BSX N/A
- DHR 0.61%
- EPS Growth
- BSX 54.68
- DHR N/A
- EPS
- BSX 1.87
- DHR 4.87
- Revenue
- BSX $19,349,000,000.00
- DHR $24,268,000,000.00
- Revenue This Year
- BSX $21.04
- DHR $3.72
- Revenue Next Year
- BSX $11.45
- DHR $3.99
- P/E Ratio
- BSX $53.49
- DHR $43.14
- Revenue Growth
- BSX 21.61
- DHR 2.21
- 52 Week Low
- BSX $85.98
- DHR $171.00
- 52 Week High
- BSX $109.50
- DHR $258.23
- Technical
- Relative Strength Index (RSI)
- BSX 50.50
- DHR 47.41
- Support Level
- BSX $97.45
- DHR $208.90
- Resistance Level
- BSX $102.27
- DHR $216.11
- Average True Range (ATR)
- BSX 1.85
- DHR 5.50
- MACD
- BSX -0.11
- DHR -1.37
- Stochastic Oscillator
- BSX 28.98
- DHR 5.65
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.